Alka-seltzer spike. tab., No. 10

Amount in a package

ten

Dosage form

soluble tablets

Manufacturer

Bayer Pharma AG, Germany

Structure

1 effervescent tablet contains:

acetylsalicylic acid 325 mg

sodium bicarbonate 1625 mg

citric acid 965 mg.

pharmachologic effect

Alka-Seltzer has analgesic, anti-inflammatory, antipyretic, antiaggregatory effects.

Inactivates cyclooxygenase, disrupts the synthesis of PG, prostacyclins and thromboxane.

Bicarbonate neutralizes free hydrochloric acid in the stomach, reducing the likelihood of NSAID gastropathy.

Indications

Headache,

gastrointestinal discomfort

heartburn,

general malaise.

Application during pregnancy and lactation

It is advisable for children and adolescents to prescribe Alka-Seltzer only if other drugs are ineffective.

Alka-Seltzer During pregnancy, Alka-Seltzer is contraindicated.

During breastfeeding, when taken in medium doses, interruption of breastfeeding is usually not required.

With regular intake of high doses of Alka-Seltzer, the issue of stopping breastfeeding should be resolved.

Contraindications

chronic or recurring symptoms of nausea, stomach pain

renal dysfunction

increased tendency to bleed

bronchial asthma.

Side effects

nausea, lack of appetite, pain in the stomach, gastrointestinal bleeding

allergic reactions

decrease in platelets in the blood.

Interaction

Reduces the effect of anti-gout drugs (including side effects), enhances anticoagulants and oral hypoglycemic drugs, NSAIDs, side effects of methotrexate.

How to take, course and dosage

for adults, a single dose - 1-2 tab, daily dose - up to 8 tab.

For children over 3 years old, a single dose is 0.5-1.5 tab.

daily dose - 1-4 tab.

Overdose

Symptoms

Moderate overdose: nausea, vomiting, tinnitus, hearing impairment, headache, dizziness and confusion.

These symptoms disappear when the dose of the drug is reduced.

4 Severe overdose: fever, hyperventilation, ketosis, respiratory alkalosis, metabolic acidosis, coma, cardiogenic shock, respiratory failure, severe hypoglycemia.

Treatment: hospitalization, lavage, intake of activated charcoal, monitoring of acid-base balance, alkaline diuresis in order to obtain urine pH between 7.5-8 (forced alkaline diuresis is considered achieved if the concentration of salicylates in plasma is more than 500 mg / l ( 3.6 mmol / L) in adults or 300 mg / L (2.2 mmol / L) in children), hemodialysis, fluid replacement, symptomatic therapy

Special instructions

Alka-Seltzer should be used with caution in patients with bronchial asthma, allergies, as well as in patients with hypersensitivity to painkillers and anti-inflammatory drugs.

Release form

Effervescent tablets.

Round, flat white tablets, engraved on one side ALKA SELTZER" in a convex circle protruding along the perimeter.

The reverse side is chamfered.

2 effervescent tablets in a strip of paper laminated with aluminum foil

1, 3, 5, 6 or 10 strips with instructions for use in a cardboard box

Storage conditions

At a temperature not exceeding 25 В° C

Shelf life

3 years

Brand name

ALKA-SELTZER

Active substance

Acetylsalicylic acid, Citric acid, Sodium bicarbonate

Terms of dispensing from pharmacies

Without recipe

Name ENG

ALKA SELTZER

Clinical and pharmacological group

NSAIDs

ATX code

Acetylsalicylic acid in combination with other drugs (excluding psycholeptics)

Dosage

324mg + 965mg + 1.625g

Structure

1 effervescent tablet contains: acetylsalicylic acid 325 mg.

sodium bicarbonate 1625 mg.

citric acid 965 mg.

Indications

Symptomatic treatment of pain syndrome of mild to moderate severity: headache (including after alcohol consumption), toothache, sore throat, pain in the back and muscles, joint pain,

pain during menstruation, increased body temperature with colds and other infectious and inflammatory diseases (in adults and children over 15 years old).

Contraindications

Hypersensitivity to acetylsalicylic acid and other NSAIDs or other components of the drug

erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase)

hemorrhagic diathesis

the combined use of methotrexate at a dose of 15 mg per week or more

complete and incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses and intolerance to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (including in history)

pregnancy (I and III trimester), breastfeeding period.

the drug is not prescribed to children under 15 years of age with acute respiratory diseases caused by viral infections, due to the risk of developing Reye's syndrome 3 (encephalopathy and acute fatty degeneration of the liver with acute development of liver failure).

INN / Active ingredient

Acetylsalicylic acid + citric acid + sodium bicarbonate

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Alcoholism

Scope of the medicinal product

General

Release form

Tablet

Manufacturer country

Germany

Package quantity, pcs

ten

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Alka-seltzer

The amount of the dosage form in the primary package

2 pcs.

Primary packaging type

Cell-free contoured packaging (strip)

Type of consumer packaging

Pack of cardboard

Dosage form

Effervescent tablets

The target audience

Children

Expiration date in days

1095

Package weight, g

fifty

Mode of application

:

for adults, a single dose - 1-2 tab, daily dose - up to 8 tab.

< br> For children over 3 years old, a single dose - 0.5-1.5 tab. < br> a daily dose - 1-4 tab.

Pharmaco-therapeutic group

:

Combined analgesic (NSAID + antacid)

Anatomical and therapeutic characteristics

:

N02BA51 Acetylsalicylic acid, in combination with other drugs (excluding psychotropic drugs)

Dosage (volume) of the substance in the preparation

:

acetylsalicylic acid 325 mg sodium bicarbonate 1625 mg citric acid 965 mg

Information on technical characteristics, delivery set, country of manufacture "